pI: 6.2828 |
Length (AA): 247 |
MW (Da): 27514 |
Paralog Number:
5
Signal peptide: N | GPI Anchor: | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 2 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
18 | 247 | 5ed4 (A) | 18 | 247 | 99.99 | 0 | 1 | 2.18137 | -1.88 |
21 | 77 | 1a04 (A) | 7 | 65 | 33.00 | 0 | 0.54 | 0.549469 | 0.08 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Resolution | Method | # Atoms | # Residues | Dep. Date | Pub. Date | Mod. Date |
---|---|---|---|---|---|---|
Resolution | Method | # Atoms | # Residues | Dep. Date | Pub. Date | Mod. Date |
---|---|---|---|---|---|---|
Resolution | Method | # Atoms | # Residues | Dep. Date | Pub. Date | Mod. Date |
---|---|---|---|---|---|---|
Resolution | Method | # Atoms | # Residues | Dep. Date | Pub. Date | Mod. Date |
---|---|---|---|---|---|---|
Resolution | Method | # Atoms | # Residues | Dep. Date | Pub. Date | Mod. Date |
---|---|---|---|---|---|---|
Resolution | Method | # Atoms | # Residues | Dep. Date | Pub. Date | Mod. Date |
---|---|---|---|---|---|---|
Resolution | Method | # Atoms | # Residues | Dep. Date | Pub. Date | Mod. Date |
---|---|---|---|---|---|---|
Resolution | Method | # Atoms | # Residues | Dep. Date | Pub. Date | Mod. Date |
---|---|---|---|---|---|---|
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | Dormant phase. | hasan |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Mid 40-60% percentile | Dormant phase. | murphy |
murphy | Identification of gene targets against dormant phase Mycobacterium tuberculosis infections. |
hasan | Prioritizing genomic drug targets in pathogens: application to Mycobacterium tuberculosis. |
Ortholog group members (OG5_128013)
Species | Accession | Gene Product |
---|---|---|
Escherichia coli | b1969 | response regulator family protein |
Escherichia coli | b4113 | response regulator in two-component regulatory system with BasS |
Escherichia coli | b0571 | response regulator in two-component regulatory system with CusS |
Escherichia coli | b3025 | quorum sensing DNA-binding response regulator in two-component regulatory system with QseC |
Mycobacterium leprae | ML2123 | TWO COMPONENT RESPONSE TRANSCRIPTIONAL REGULATORY PROTEIN PRRA |
Mycobacterium leprae | ML0174 | Mycobacterial persistence regulator MrpA (two-component response transcriptional regulatory protein) |
Mycobacterium tuberculosis | Rv0903c | Two component response transcriptional regulatory protein PrrA |
Mycobacterium tuberculosis | Rv0602c | Two component DNA binding transcriptional regulatory protein TcrA |
Mycobacterium tuberculosis | Rv0757 | Possible two component system response transcriptional positive regulator PhoP |
Mycobacterium tuberculosis | Rv0981 | Mycobacterial persistence regulator MRPA (two component response transcriptional regulatory protein) |
Mycobacterium tuberculosis | Rv3765c | Probable two component transcriptional regulatory protein TcrX |
Mycobacterium tuberculosis | Rv1033c | Two component transcriptional regulator TrcR |
Mycobacterium ulcerans | MUL_0248 | two component response transcriptional regulatory protein PrrA |
Mycobacterium ulcerans | MUL_4624 | two component transcriptional regulator TrcR |
Mycobacterium ulcerans | MUL_4391 | two component transcriptional regulatory protein TcrX |
Mycobacterium ulcerans | MUL_4701 | two component response transcriptional regulatory protein MprA |
Mycobacterium ulcerans | MUL_0463 | two component system response phosphate regulon transcriptional regulator, PhoP |
Schmidtea mediterranea | mk4.105972.00 | |
Schmidtea mediterranea | mk4.042982.00 | |
Trypanosoma congolense | TcIL3000_0_45650 | heavy metal response regulator, putative |
Wolbachia endosymbiont of Brugia malayi | Wbm0596 | response regulator |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
mtu772 this record | Mycobacterium tuberculosis | non-essential | nmpdr |
mtu3830 | Mycobacterium tuberculosis | non-essential | nmpdr |
mtu1050 | Mycobacterium tuberculosis | non-essential | nmpdr |
b0571 | Escherichia coli | non-essential | goodall |
b1969 | Escherichia coli | non-essential | goodall |
b3025 | Escherichia coli | non-essential | goodall |
b4113 | Escherichia coli | non-essential | goodall |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Druggability index (range: 0 to 1): 0.2